Seven years after its inception, the FDA has finalized its first guidance on the Voluntary Malfunction Summary Report (VMSR) program for medical devices. While industry groups had asked for some additional flexibility and clarity in response to the draft version of the document, the agency largely finalized the document in alignment with that 2022 draft.
Fill out the form to read the full article.
Required *